Schedule 13G ownership disclosure

Arcturus Therapeutics Holdings Inc

Security class unavailable · CUSIP: 03969T109

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,694,929
Percent of class
14.0200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001623632-22-000216
Form type
SC 13G
Filer
Arcturus Therapeutics Holdings Inc.
CIK
CIK 1768224
Filed
Feb 14, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub